Concert Pharmaceuticals, Inc. Deferred Costs, Current
Concert Pharmaceuticals, Inc. had Deferred Costs, Current of $15.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Balance Sheet › Assets › Assets, Current › Deferred Costs, Current
us-gaap:DeferredCostsCurrent · last filed 2022-11-07
- 2022-09-30: Deferred Costs, Current $15.00K.
- 2022-06-30: Deferred Costs, Current $0.00.
- 2022-03-31: Deferred Costs, Current $0.00.
- 2021-12-31: Deferred Costs, Current $15.00K.
| Period end | Deferred Costs, Current |
|---|---|
| 2022-09-30 | $15.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 |
| 2021-12-31 | $15.00K 10-Q · filed 2022-11-07 |
| 2021-09-30 | $42.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $15.00K 10-Q · filed 2021-08-05 |
| 2020-12-31 | $0.00 10-Q · filed 2021-11-09 |
| 2020-09-30 | $139.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $43.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $0.00 10-Q · filed 2020-04-30 |
| 2019-12-31 | $143.00K 10-Q · filed 2020-11-05 |